Zoledronic acid versus bisphosphonates following teriparatide therapy in patients with osteoporosis

Trial Profile

Zoledronic acid versus bisphosphonates following teriparatide therapy in patients with osteoporosis

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2011

At a glance

  • Drugs Zoledronic acid (Primary) ; Alendronic acid; Risedronic acid; Teriparatide
  • Indications Male osteoporosis; Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2011 New trial record
    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top